During the past decade, PHCC LP conducted 0 clinical trials. In the 10-year time frame, 0 clinical trials started and 1 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

In terms of collaborators to trials, out of the total clinical trials conducted in "PHCC LP" #1 collaborator was "National Heart, Lung, and Blood Institute (NHLBI)" with 1 trials as a collaborator. Other collaborators include -1 different institutions and companies that were collaborators in the rest 1 trials.

According to Clinical.Site data, the most researched conditions in "PHCC LP" are "Cardiovascular Diseases" (1 trials), "Low Birth Weight <2500 Grams" (1 trials), "Preterm Birth" (1 trials) and "Verylow Birthweight <1500 Grams" (1 trials). Many other conditions were trialed in "PHCC LP" in a lesser frequency.

Most popular intervention types in "PHCC LP" are "Behavioral" (2 trials). Other intervention types were less common.

The name of intervention was led by "Medication Adherence System (MAS)" (1 trials), "Usual Care" (1 trials) and "lifestyle support" (1 trials). Other intervention names were less common.

The vast majority of trials in "PHCC LP" are 1 trials for "All" genders and 1 trials for "Female" genders.

Currently, there are NaN active trials in "PHCC LP". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 2 completed trials in PHCC LP, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in PHCC LP, 0 "Phase 1" clinical trials were conducted, 2 "Phase 2" clinical trials and 0 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".